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The relationship of infections with certain types of group A  streptococci (nephri- 
togenic streptococci) to the subsequent  development of acute poststreptococcal glo- 
merulonephritis  (APSGN) 1 has been clearly established  (1).  However, this is not a 
constant phenomenon since the incidence of APSGN has varied considerably in those 
individuals infected with nephritogenic types of streptococci (2). These observations 
have  suggested  as  one  possible  explanation  that  only certain  strains  within  these 
nephritogenic types have the capability of inducing this disease. 
The mechanisms by which only a  limited number of nephritogenic streptococcal 
strains exert their noxious effects upon the glomerulus have not been clearly eluci- 
dated. One school of thought postulates that streptococcal antigen-antibody interac- 
tions initiate the immunological damage  (3, 4). Others propose that an endogenous 
immune  complex  system  initiated  by  the  streptococcus  could  be  of pathogenic 
significance;  either  streptococcal  antigens  cross-reactive  with  components  of the 
human  glomerulus  (5)  or alteration by streptococcal products of human  immuno- 
globulin  molecules  (6).  A  third  point  of view  suggests  that  direct  complement 
activation by streptococcal components without the participation of immunoglobulins 
is of primary importance in some cases of APSGN (7, 8). 
In an effort to determine the streptococcal antigen(s)  involved, two main avenues 
of investigation have been explored. Using immunofluorescence techniques, Seegal et 
al. (3) have suggested that the antigen in question is part of the streptococcal cell wall 
complex and limited only to nephritogenic types of streptococci. In contrast, Lange et 
al. (4) have reported that the antigen lies within the streptococcal cell and is unrelated 
to  the  serological  type  of the  streptococcus.  The  second  approach  has  been  the 
examination  of structural  and  biological  differences  between  nephritogenic  and 
nonnephritogenic strains of streptococci. In general, these studies have been inconclu- 
sive or controversial (9).  The possible reasons for these discrepancies might  be the 
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complex nature of the streptococcal cell  (10),  the excretion of many different extra- 
cellular products (11), and the marked variation in the production of these extracel- 
lular proteins by a  given strain (12). 
Although  aware  of the  difficulties  inherent  in  comparing  multiple  extracellular 
products  in  various  streptococcal  strains,  we  decided  to  re-explore the  question  of 
whether  nephritis-producing  strains  of streptococci preferentially excreted  an  anti- 
gen(s) unique to these strains for the following reasons. First we were encouraged by 
the appearance of new biochemical methods capable of detecting minute differences 
in the protein composition of microbial products (13). These techniques could provide 
a powerful tool with which to examine the differences in the extracellular proteins of 
those strains which did or did not cause APSGN. Second, an analysis of the antigen(s) 
in its naturally occurring form might provide valuable insight into the biological and 
structural properties of the protein in question. This assumes some importance because 
many of the current methods of protein extraction from streptococcal cells (14) could 
destroy the antigen under study or produce a  larger molecule in which the relevant 
antigenic sites were buried  (15). 
The present  report  demonstrates that  the extracellular  products  of streptococcal 
strains isolated from patients with APSGN possess a protein which is unique to these 
strains. This protein is generally not produced by streptococci recovered from patients 
without  APSGN.  It  appears to  be similar in  those  strains of streptococci obtained 
from patients with APSGN irrespective of the serotype and can be demonstrated by 
immunofluorescent techniques in the kidney biopsies of these patients. 
Materials and Methods 
Streptococcal Strains.  46 streptococcal strains from The Rockefeller University collection were 
used for this study (Table I in  Results  section).  21  were isolated  from patients with clinical 
and/or pathological diagnoses of APSGN and 25 were isolated from patients with suppurative 
and nonsuppurative sequelae other than APSGN. Five additional group A streptococcal strains 
recovered from patients with APSGN were also employed. Three of these were mouse passed 
after the initial isolation:  strains T12/126/4  (type 12), A995/91/1  (type 57), and A928/73/1 
(type 49). Strains A374 and A547 originally isolated from patients with APSGN were repeatedly 
subcultured in rabbit blood neopeptone broth containing 4% rabbit blood and Todd-Hewitt 
dialysate medium (Difco Laboratories, Detroit, Mich.). 
Culture Broth.  Todd-Hewitt dialysate medium was prepared following methods previously 
described from this laboratory (16) and sterilized  by autoclaving. The dialysate medium was 
chosen  in an effort to eliminate contaminating broth proteins greater than  10,000 daltons in 
the analysis of the streptococcal extracellular proteins. 
Preparation of Streptococcal Extracellular Proteins (SEP).  Lyophilized streptococcal strains were 
grown in 5 ml of neopeptone broth with 4% rabbit blood for 18 h at 37°C. 0.1 ml of this culture 
was subcultured twice in 250 ml of Todd-Hewitt dialysate media for 18 h at 37°C with the 
purpose of diluting and eliminating the contaminating rabbit blood proteins.  10 ml of the 
second 250 ml stationary phase culture were transferred to three flasks each containing 2 liters 
of Todd-Hewitt dialysate medium. The individual flasks were allowed  to grow at 37°C  for 
varying periods (5, 18, and 48 h) to study the SEP during the exponential, early stationary, and 
late stationary phases of growth, respectively.  In some experiments the optical density was 
measured  (560 nm)  at frequent  intervals on a  Beckman Quartz spectrophotomer (National 
Technical Laboratories, South Pasadena, Calif.) to obtain cultures with similar growth density 
and to compare their SEP. The purity of each culture was assessed by rabbit blood agar plating. 
The organisms were removed from each of the 2-liter cultures by centrifugation at 10,000 g for 
30 min at 4°C (Sorvall  RC2B, Dupont Instruments, Newtown, Conn.). The supernates were 
filtered through a 0.22-#m  Millipore filter (Millipore Corp., Bedford,  Mass.)  and brought to 
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This material was stirred overnight at 4°C and then centrifuged at  10,000 g for 30 min at 
4°C.  The pellet was dissolved in  10 ml of 0.005  M  sodium phosphate buffer (approximately 
200-fold concentrated), placed in dialysis tubing with mol wt cutoff of 6,000-8,000  (Spectrum 
Medical Industries, Inc., Los Angeles, Calif.) and dialyzed for 18 h against 32 liters of the same 
buffer. The protein content in each of the samples was measured by the method of Lowry et al. 
(17)  and adjusted to appropriate concentrations by either dilution with 0.005  M  phosphate 
buffer or concentration through an A25 Minicon (Amicon Corporation, Scientific Sys. Div., 
Lexington, Mass.). 
Polyac~ylamide Gel Electrophoresis.  SEP of all strains were studied by sodium dodecyl sulfate 
polyacrylamide gradient gel electrophoresis (SDS-PAGGE) by using the method of Maizel (13) 
with  a  discontinuous Tris-glyeine buffer system.  Electrophoresis was carried out  on  7-30% 
gradient slab polyacrylamide gels at 50 V for 18 h. Bovine serum albumin, carbonic anhydrase, 
cytochrome C,  and  ovalbumin standards, were  run  concurrently on  the  gels for molecular 
weight determinations. Samples and standards were mixed with equal portions of a solution 
containing 2% SDS, 2% mercaptoethanol, and 30% glycerol and boiled for 2 min in a waterbath 
before loading to the gels. 
Isolation of the Nephritis Strain-Associated Protein (NSAP).  60 liters of Todd-Hewitt dialysate 
medium were sterilized by filtration into a  Biogen Fermentor (American Sterilizer Co., New 
York) through a 0.22-~m Millipore filter as previously described from this laboratory (16). The 
medium was then inoculated with 1.5 liters of a stationary phase group A, type 49, streptococcal 
culture (Gt 8760) isolated from a patient with APSGN. The culture was incubated for 5 h, and 
the streptococcal cells were removed at 4°C by using a Sharples high-speed centrifuge (Sharpies- 
Stock Division, Pennwalt Corporation, Warminster, Penn.). The supernate was then filtered 
and  treated  with  ammonium  sulfate  as described in  the  preparation of SEP  section.  The 
precipitate was collected at 4°C by Sharpies high-speed centrifugation, dissolved in 60 ml of 
0.005 M sodium phosphate buffer pH 5 (approximately 1,000-fold concentrated), and dialyzed 
extensively against the same buffer. This material was stored at 4°C with sodium azide at a 
final concentration of 0.02%  added to the solution. 
Purification of the NSAP.  Purification of the NSAP was accomplished as follows. The crude 
SEP of strain Gt 8760 were loaded into a column (15  ×  2.7 cm) of carboxy methyl cellulose 
(CM  52, Whatman  Ltd., Maidstone, Kent,  England)  previously equilibrated with 0.005  M 
sodium phosphate buffer pH 5. The same buffer was used to remove unbound material from 
the column until the effluent conductivity (Radiometer, Copenhagen) and OD at 280/~m were 
similar to that  of the eluting buffer.  A  linear gradient from 0.005  M  to 0.5  M  (550  ml) of 
sodium phosphate buffer pH 5 at a rate of 25 ml/h was used to elute the SEP. 3-ml fractions 
were collected. The  different fractions were dialyzed and  then  assayed by SDS-PAGGE to 
ascertain the presence of the NSAP. 
Fractions containing the NSAP were pooled, dialyzed against 0.1 M ammonium bicarbonate 
buffer, and lyophilized. These were then resuspended in 1.0 ml of 0.1 M ammonium bicarbonate 
buffer and loaded on a column (2.5  X  90 cm) of Sephadex G200 (Pharmacia Fine Chemicals, 
Piscataway, N.J.) previously equilibrated with the same buffer. 2-ml fractions were eluted at a 
flow rate of 8 ml/h and tested for the NSAP as previously described. The fractions containing 
the  NSAP  were  then  pooled, lyophilized, and  resuspended  in  1 ml  of 0.1  M  ammonium 
bicarbonate and  loaded onto  a  column  (1.5  ×  90  cm)  of Sephadex G75  (Pharmacia Fine 
Chemicals) equilibrated with the above buffer. The proteins were eluted with 0.1 M ammonium 
bicarbonate, collecting 1.2-ml fractions. The different fractions were again analyzed by SDS- 
PAGGE for the presence of the NSAP. The final product contained three major and eight 
minor proteins by SDS-PAGGE. 
Further purification of the partially purified NSAP from the G75 Sephadex chromatography 
step was accomplished by preparative electrophoresis from polyacrylamide gels. The partially 
purified NSAP was lyophilized and resuspended in sample loading buffer and separated by 
SDS-PAGGE as described previously in the SDS-PAGGE section. The position of NSAP in the 
gel was determined by staining the two end slots by using Coommassie Blue. The gels were 
then lined up, and the NSAP band was cut from the remainder of the gel. Separated bands 
from many gels were pooled and cut into 5-cm pieces. The NSAP was then electrophoresed 
from the polyacrylamide gel slices by using 0.01  M  Tris-glycine buffer pH 8.6 containing 0.1% 
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PAGGE. This process of electrophoresing the NSAP from polyacrylamide gels was repeated 
until only a single polypeptide was detected when analyzed by SDS-PAGGE. 
Preparation of Antisera to  the SEP.  Antisera specific for  the  NSAP  was  prepared by  two 
methods. The first method consisted of inoculating three 2-kg New Zealand Red rabbits with 
300  #g  of the  purified  NSAP  in  1 ml  incomplete Freund's adjuvant  (Difco Laboratories) 
subcutaneously into three different locations. Similar injections were administered 2 and 3 wk 
after the first inoculation. The rabbits were bled 1 wk after the final injection, and the gamma 
globulin fraction was isolated by the caprylic acid technique (19) and dialyzed (three times) 
against 10 vol of 0.02 M  sodium phosphate buffer pH 7.0. The dialyzed gamma globulin was 
then  loaded to a  column  of DEAE  cellulose (DE  52,  Whatman  Chemicals, Div.  W.  &  R. 
Balston,  Maidstone,  Kent,  England)  and  equilibrated  with  the  above  buffer.  The  tubes 
containing only gamma globulin as determined by cellulose acetate electrophoresis (20) were 
pooled and concentrated by using an Amicon stirred cell with a XM 50 membrane (Amicon 
Corp.). 
In the second method, 500 #g of the crude SEP of strain A995 containing significant amounts 
of NSAP was mixed with  1 ml of incomplete Freund's adjuvant and injected into two New 
Zealand Red rabbits (2 kg). The injections were given subcutaneously three times weekly for 5 
wk. The animals were bled 1 wk after the last inoculation and the gamma globulin fraction was 
obtained as in the first method. 
To remove antibodies to streptococcal extracellular proteins unrelated to the NSAP, the 
antiserum to the SEP of strain A995 was then absorbed with pooled crude SEP not containing 
the  NSAP.  SEP  from  strains  A995/91/1,  A834,  and  B434  were  used  for  the  absorptions. 
Absorptions were performed after coupling the pooled SEP to N-hydroxy succinamide-activated 
Sepharose (21) (Bio-Rad Laboratories, Richmond, Calif.). The gamma globulin fraction of the 
antiserum to the crude SEP of strain A995 was then added to the SEP coupled beads and 
incubated at 25°C for 2 h followed by incubation at 4°C for 18 h. The antiserum specific for 
the NSAP produced in this manner was then tested by immunodiffusion analysis. 
For control experiments, antisera to crude SEP not containing NSAP (strain A995/91/1) 
was prepared by injecting two New Zealand Red rabbits (2 kg) with 500 #g of protein in 1 ml 
of incomplete Freund's adjuvant. These injections were given subcutaneously three times a 
week for 5 wk. The animals were bled 1 wk after the last inoculation, and the gamma globulin 
fraction was prepared as previously outlined. 
Immunodiffusion Studies.  Slides for double diffusion precipitin tests were prepared by placing 
a  solution  (3  ml)  of 1%  agarose  (Matheson, Coleman  and  Bell, Norwood, Ohio)  in  0.1  M 
barbital buffer, pH 8.6, onto microscope slides. Wells were cut immediately before use and then 
filled with the appropriate antigen solutions and antisera. The slides were then placed in a 
moist chamber and read 24 and 48 h later. 
Immunofluorescence Studies.  Isolated gamma globulin fractions of the rabbits described above 
were adjusted to a  concentration of 10 mg/ml with 0.5 M  sodium carbonate buffer pH 9.5, 
conjugated with fiuorescein isothiocyanate (BioQ.uest,  BBL, & Falcon Products, Becton, Dick- 
inson,  &  Co.,  Cockeysville, Md.)  and  separated  from  the  free  dye by  methods  previously 
described (16). The conjugated gamma globulin was aliquoted into 1-ml samples and stored at 
-70°C until used. 
For preparation of the goat anti-rabbit gamma globulin, inocula and immunization schedules 
were made according to the method of van de Rijn et al. (16). 
For the immunofluorescence assay, desiccated 4 #m frozen kidney sections were prepared by 
the method ofKoffler et al. (22) and then incubated with various dilutions of: (a) fluoresceinated 
rabbit anti-human IgG, IgM, C3, fibrinogen (Behring Diagnostics, American Hoechst Corp., 
Somerville, N.J.), (b) fiuoresceinated rabbit antiserum to the crude SEP containing the NSAP, 
(c) antisera to the purified NSAP obtained by both methods, and (d) antisera to the crude SEP 
not  containing the NSAP. The slides were analyzed for the presence of immunofluorescent 
staining using a Zeiss Universal ultraviolet microscope (Carl Zeiss, Inc., New York) with BG12 
and 440/ma  filters. The fluorescence was graded on a  0-4+  scale with 4+  representing the 
greatest intensity of staining. The indirect immunofluorescence assay was performed as previ- 
ously described (16). 
Kidney Biopsies.  Percutaneous kidney biopsies used in this study were longitudinally divided 
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Fro.  1.  SEP  patterns of 11  group  A strains  of different  serotypes.  100 #1 of each  preparation 
isolated from 5-h grown cells were loaded onto an SDS gel as described in Materials and Methods. 
Note the marked variation in the number of  proteins produced by the different types of  streptococci. 
Strains:  I, A547; 2, A456; 3, B281; 4, A992; 5, B434; 6, 1GL1362; 7, A552; 8, A928; 9, B737; 10, 
A207; 11, D4,80. The position of the migration  of the protein standards ([BSA], ovalbumin  [OA], 
and cytochrome C [CC]) are noted. 
studies was immediately embedded in 7% gelatin (Knox, St. Paul, Minn.), frozen in a mixture 
of dry ice-isopropanol, and stored at -70°C until shipment. For transportation, the biopsies 
were placed in a  sealed container with dry ice. Kidney biopsies of patients with APSGN were 
provided by Dr.  R.  Mahabir from  the  San  Fernando General  Hospital in  Trinidad, West 
Indies. Kidney biopsies of patients with acute rheumatic fever were supplied by Dr. Villarreal, 
Sr., from the National Institute of Cardiology of Mexico, and kidney biopsies of patients with 
other glomerulopathies, such as lupus nephritis, minimal change disease, membranous nephritis, 
as well as normal human autopsy kidney, were provided by Dr. C. Becker from the New York 
Hospital, Cornell University Medical Center. 
Absorption Studies with Antiserum to the NSAP.  " For absorption studies, 20 #1 of fluoresceinated 
or untagged rabbit anti-NSAP antisera were placed in microfuge tubes containing 20/.d of the 
following preparations: (a) crude SEP containing the NSAP (over 60 protein bands on SDS- 
PAGGE),  (b)  crude SEP that did not possess the NSAP,  (c)  a  partially purified preparation 
containing the NSAP isolated from  G75 chromatography,  (at) and the purified NSAP. The 
contents were allowed to incubate at 37°C for 2 h  and then overnight at 4°C. Before use, the 
samples were centrifuged for 5 min at 23°C in a  microfuge 152  (Beckman Instruments, Inc., 
Cedar Grove,  N. J.)  and  the  supernatant  fluid was  used  in  the  immunofluorescence assay. 
Unabsorbed antiserum to the purified NSAP which was diluted in the same proportions and 
incubated for the same periods of time was used as the 4+  staining control. All dilutions were 
done with 0.01  M  phosphate buffer pH 7;6. 
Results 
Examination  of the  SEP from  Various  Strains  by  SDS-PAGGE.  When  the  SDS  gels 
containing the SEP of 44 group A  strains were compared, a  marked variability in the 
number of protein bands was observed. Fig.  1 shows a  representative gel where it can 
he seen that SEP of some strains showed numerous protein bands while in others only 
a  few were detected. The mol wt of these protein bands ranged from about 80,000 to 
10,000  dahons.  It was not  possible to assess the presence of SEP with tool wt below 
10,000  daltons  due  to  the  presence  of contaminating  low  molecular weight  media 
peptides. 
Because  no  consistent  differences  were  observed  in  a  wide  variety  of  random 
streptococcal  strains  examined,  experiments  designed  to  look  at  the  extracellular 
products from nephritogenic versus nonnephritogenic serotypes were carried out. The 464  EXTRACELLULAR PRODUCTS OF  STREPTOCOCCI 
FIG. 2.  SEP of six group A type 12 strains. 100 p,l of each preparation isolated from a constant 
culture density was loaded onto an SDS gel as noted in Materials and Methods. Note again the 
marked variation in the number of proteins excreted by these strains. Strains: 1, T12; 2, T12 M +; 
3, T12 M-; 4, T12/126/4; 5, B923; 6, A374. The position of migration of the protein standards are 
noted. 
SEP of strains known to be capable of inducing APSGN, such as types 2,  12,  18, 49, 
55, 57, were compared to those strains not previously described as causing this disease; 
i.e., types 3, 9,  19,  30, 36.  In general, the nephritogenic  SEP tended  to possess more 
protein  bands  than  the  nonnephritogenic  ones,  but  on  occasion  the  opposite  was 
observed. 
To  determine  whether  variation  existed  within  a  single  streptococcal  serotype, 
several group A strains of similar serotypes were compared. Eight type 12 strains, five 
type 4  strains,  and  five type 49 strains were examined.  Fig.  2 shows the  SEP of six 
type  12  strains.  Once  again,  marked  differences  in  the  number  of protein  bands 
present was observed.  Strain-to-strain variation of the SEP persisted even when the 
numbers of streptococci in the cultures as measured by the optical density was kept 
constant  or  the  protein  concentration  of each  strain  studied  was  equalized.  These 
differences  also  occurred  in  samples  taken  at  specific  times  (5,  18,  48  h)  after 
inoculation. 
Examination of  the SEP of  Strains Isolated  from Patients with and without A PSGN.  Although 
it  was  hot  possible  to  demonstrate  that  strains  commonly  labeled  nephritogenic 
excreted  proteins  that  were different  from nonnephritogenic  strains,  the  possibility 
arose that consistent differences might exist in strains directly isolated from patients 
with  APSGN  irrespective  of  the  serotype.  Fig.  3  illustrates  the  results  of  these 
experiments. While the variation in protein bands between these group A  strains is 
again apparent, an examination of the gels showed that a  protein band' with tool wt 
of ~  46,000  dahons  (NSAP)  (arrows)  occurred  mainly  in  the  SEP  of the  strains 
recovered from patients with APSGN. This band was not present in the SEP of those 
strains of similar serotypes recovered from patients without this disease. 
Table I  shows that  of 21  strains isolated from patients with APSGN,  19 had the 
NSAP;  the  only exceptions were one  type 5  and  one  type 55  strain  obtained  from 
patients  with  clinical  diagnoses  of APSGN.  Of 25  group  A  strains  recovered  from 
patients without APSGN (16 of which were similar in serotype to those isolated from 
patients with APSGN), only two showed the NSAP, and both were type 12 strains. 5 
h  of culture were usually sufficient for the NSAP to be detected by SDS-PAGGE in H.  VILLARREAL,  V.  A.  FISCHETTI,  I.  VAN  DE  RIJN,  AND J.  B.  ZABRISKIE  465 
Fro.  3.  SEP of four group A streptococcal strains. 100 #1 of each preparation was loaded onto an 
SDS gel as noted in Materials and Methods. Sections 1 (type 2) and 3 (type  12) are extracellular 
products obtained from strains isolated from patients with APSGN. Sections 2 (type 2) and 4 (type 
12)  are  SEP  recovered from strains obtained  from  patients without APSGN.  Note  (arrow)  the 
presence of a protein band with mol wt of 46,000 daltons (NSAP) only in the strains isolated from 
patients with APSGN. 
TABLE  I 
Presence of the NSAP in Various Streptococcal Strains 
Group type 
Source of strains 
APSGN patients  Non-APSGN patients 
A  1 
2 
3 
4 
5 
9 
12 
18 
19 
30 
36 
49 
50 
55 
57 
NT* 
NSAP + 
F203D 
A207 
B512, B905, B974 
NSAP-  NSAP+ 
B743 
A374, B281, B923  D313 
Gt7940, Gt7899  L92541 
t12 
B438 
B915, B920, Gt8760 
A995 
B515, A218, A547 
A928 
NSAP- 
D480 
B931 
A830, A868 
A915, A990 
A964, B434 
A552, A728 
D897 
L02407 
L01596 
A992 
1GL362 
1GL22 
A456 
B737, A834 
A315 
D438 
D  B272, B443 
Strains  19  2  2  23 
* Nontypable strains. 
the SEP  of the throat  strains studied.  Further  incubation  (up  to 48 h)  generally  did 
not result in an increased production  of the NSAP.  However, the prolonged incubation 
up  to  48  h  resulted  in  the  appearance  of new  protein  bands.  The  NSAP  was  not 
detected  in the negative strains even when  the  SEP  were concentrated  2,000-fold  at 
various times of growth  (up to 48 h). 466  EXTRACELLULAR PRODUCTS OF  STREPTOCOCCI 
FIG. 4.  SEP of strain A995 isolated from a patient with APSGN. 100/~1 of SEP obtained from the 
strain before (section 1) and after (section 2) mouse passage was loaded onto the gel. Note the loss 
of the NSAP (arrow) after 91 mouse passages. The position of migration of the molecular weight 
standards are noted. 
It  was of interest  that  the  skin  strains  obtained  from patients  with  APSGN  also 
showed the NSAP. However, they differed from the throat strains in that this protein 
was  not,  or  only  faintly  apparent,  in  5-h  cultures.  Incubation  for  18  or  24  h  was 
necessary for this band to be detected. 
Loss of the NSAP after Mouse Passage or Subcultures.  It has been well established  that 
mouse  passage  results  in  the  selection  of high  producers of type-specific M  protein 
(23). To determine if this procedure also increased the production of the NSAP, three 
streptococcal strains were mouse passed. These experiments resulted in the disappear- 
ance of the NSAP  (Fig.  4).  In contrast, certain other proteins  increased after mouse 
passage. In a similar manner, repeated subcultures in the growth medium also resulted 
in the disappearance of the NSAP. 
Gel Analysis of the Purified NSAP.  Although the protein band was clearly visible in 
each of the SEP of the strains isolated from patients with APSGN, many other protein 
bands were also present.  Therefore, purification steps were carried out in an effort to 
further characterize  the NSAP and  to prepare  antisera  against  the purified  protein. H.  VILLARREAL, V.  A.  FISCHETTI, I.  VAN DE  RIJN,  AND  J.  B.  ZABRISKIE  467 
FIG. 5.  SDS polyacrylamide gel electrophoresis of the purified NSAP. An aliquot of the NSAP 
isolated by electrophoresis from acrylamide gels was rerun on SDS-PAGGE to determine its purity. 
Only a single polypeptide with wt of 46,000 was resolved when the gel was stained with Coomassie 
Blue. 
By  using  ion  exchange,  molecular  sieve  chromatography,  and  the  electrophoresis 
procedures outlined  in the Materials  and  Methods section, it was possible to obtain 
the purified  protein.  Fig.  5  is  an  SDS  gel pattern  of this  protein  and  shows only a 
single band. This material was then used for production ofantisera and the absorption 
studies to be described below. 
Examination  of the SEP of the Strains Studied by Double Diffusion Analysis.  To assess the 
specificity of the antiserum  to the NSAP, the following double diffusion studies were 
carried out. When antiserum  to the NSAP obtained by the first method was reacted 
with  the purified  NSAP or with crude SEP from strains  isolated from patients  with 
APSGN  (NSAP present),  a  faint  and  broad precipitin  line was formed.  However, a 
single, more distinct preeipitin line was observed when antiserum specific to the NSAP 
(obtained  by absorptions  with  crude  SEP  from strains  without  NSAP)  was reacted 
with crude  SEP containing NSAP  (strain  L02541).  This preeipitin  line disappeared 
when this antiserum  to the NSAP was absorbed with the purified NSAP (Fig. 6). To 
determine  whether  the  small  amount  of SDS  contaminant  present  in  the  purified 
NSAP  preparation  could  be  responsible  for  the  inhibition  of the  precipitin  line, 
purified  NSAP was  added  to  a  rabbit  antiserum  to  bovine serum  albumin  (BSA). 
The addition  of the NSAP to this  antiserum  did not prevent  its  reaction  in  double 
diffusion with BSA. 
Whether or not the NSAP present in each of the SEP of strains of various serotypes 
isolated  from  patients  with  APSGN  was  the  same  protein  was  determined  in  the 
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FIo. 6.  A photograph  of an  immunodiffusion slide in which well  1 contains the  SEP  (NSAP 
present) of strain LO2541 (group A, type  12). Well 2 contains antiserum to the NSAP absorbed 
with the SEP of strains in which the NSAP is not present. Well 3 contains the antiserum to the 
NSAP which was absorbed with the purified NSAP. Note that a line of precipitation only appears 
between the crude SEP and the antiserum to the NSAP not absorbed with the purified protein. 
FIG.  7.  A photograph  of an immunodiffusion slide in which the center well contains antiserum 
specific to the NSAP. Wells 1-3 contain the SEP of three group A strains isolated from patients 
with APSGN. Well 4 contains the SEP of a mouse passed strain. Wells 5 and 6 contain the SEP of 
strains obtained  from patients without  APSGN. Note the line of identity formed only by those 
strains isolated from patients with APSGN (for details, see text). 
reacted with crude  SEP of strains  isolated  from patients  with and without  APSGN. 
Fig. 7 is illustrative of one of these double diffusion studies. Antiserum specific for the 
NSAP was  added  to the center  well.  In wells  1-3  the crude  SEP of three  group A 
streptococcal strains isolated from patients with APSGN was placed. These SEP were 
obtained  from  strains  B281  (type  12),  Gt  8760  (type  49),  and  A995  (type  57), 
respectively.  Wells  4-6  contained  the crude  SEP  of three  group A  strains  obtained 
from patients  without  APSGN  or mouse  passed  strains  (no  NSAP present),  strains 
A995/91/1  (type  57),  A  834  (type 49),  and  D897  (type  12),  respectively.  A  line  of 
identity was formed by the SEP of the three  strains  isolated  from APSGN patients. 
No precipitin  line  formed with  the  SEP  of strains  recovered  from patients  without 
APSGN or mouse passed strains. 
Immunofluorescent Studies in Kidney Biopsy Specimens.  Because the NSAP was primarily 
found in the extracellular products of streptococci isolated directly from patients with 
APSGN, we decided to examine  21  kidney biopsies of patients  with APSGN for the 
presence or absence of this protein.  These were also studied  for the presence of IgG, 
IgM, C3, and fibrinogen. 
14 of 21 biopsies from patients with APSGN showed moderate fluorescence deposits 
when fluoresceinated antiserum specific to the NSAP was employed. The fluorescence 
increased  markedly  when  an  indirect  immunofluorescence  method  was  used.  The 
deposits were finely granular  and  found both along the glomerular basement  mem- 
brane  and  mesangium  (Fig.  8).  The positive biopsies of patients  with APSGN were 
usually those that  also had deposits of IgG. In contrast,  5 kidney biopsies of patients 
with  acute  rheumatic  fever and  11  from other  nonstreptococcal  glomerulonephritis 
patients, such as membranous nephritis, lupus nephritis, and minimal change disease, 
were all  negative  for the NSAP  (Table  II). The antiserum  to crude  SEP containing 
the  NSAP  produced  similar  fluorescence  in  the  kidney  biopsies  of patients  with 
APSGN as did the antiserum  to the purified  NSAP. In contrast, antiserum  to crude H.  VILLARREAL,  V.  A.  FISCHETTI,  I.  VAN  DE  RIJN,  AND J.  B.  ZABRISKIE  469 
FIG. 8.  Glomerulus of a  patient with  early  well-documented  APSGN  stained  with  antiserum 
specific to the NSAP.  Note the presence of granular deposits of this antigen along the glomerular 
basement membrane and mesangium X 384. 
TABLE  II 
Results of lmmunofluorescence Studies in Kidney Biopsies 
Acute post-  Other nonstrep- 
streptococcal  Acute rheu- 
Antiserum to:  glomerulone-  matic fever  tococcal glo- 
phritis  merulonephritis 
Crude SEP of strain A995 (NSAP present)  7/12"  0/5  0/10 
Purified NSAP strain Gt8760  14/21  0/5  0/11 
Crude SEP of strain A995/91/1 (no NSAP present)  0/21  0/5  0/9 
* Positive/total. 
TABLE  III 
Absorption Studies in Kidney Biopsies of Patients with Acute Poststreptococcal 
Glomerulonephritis with Antiserum Specific to the NSAP 
Fluorescence posi-  Absorption with:  tive/total 
None  11  / 11 
Crude SEP containing NSAP (strain Gt8760)  0/11 
Partially purified SEP containing NSAP (strain Gt8760)  0/11" 
Purified NSAP (strain Gt8760)  0/11 
Crude SEP not containing NSAP (strain A995/91/1)  11/11 
Concentrated Todd-Hewitt media dialysate  5/5 
SEP  without  the  NSAP  failed  to  exhibit  fluorescence in  the  same  biopsies.  The 
fluorescence was  abolished  from the APSGN  biopsies when  the  rabbit  anti-NSAP 
gamma  globulin  was  absorbed  with  crude,  partially  purified  or  purified  NSAP. 
Absorptions with crude SEP which did not contain NSAP or lyophilized Todd-Hewitt 
media did not abolish the fluorescence (Table III). 
Discussion 
The analysis of the extracellular proteins of streptococci by SDS-PAGGE revealed 
marked  qualitative  and  quantitative  differences in  their  excreted  proteins.  These 
differences were noted even when  the time of harvest,  mass  of organisms,  or total 470  EXTRACELLULAR PRODUCTS OF STREPTOCOCCI 
extracellular proteins  were equalized.  The  variations  in  the  extracellular proteins 
occurred not  only among  the  different types of streptococci but  also  in  strains  of 
similar serotypes. Furthermore, in those strains tested it was found that mouse passage 
or repeated subcultures of a particular strain resulted in changes in the amount and 
number of proteins excreted. 
At first, these variations prevented us from identifying consistent differences among 
types of streptococci commonly associated with APSGN and those strains which rarely 
cause the disease. It was only after analysis of the SEP of a large number of strains of 
the same nephritogenic type that  it was  possible to identify a  single protein band 
(NSAP) which was predominantly present in the strains isolated directly from patients 
with APSGN. The unique production of this protein by those streptococcal strains 
isolated from patients with APSGN was attested to by the fact that the majority of 
strains isolated from patients without APSGN did not exhibit the NSAP. This was 
true even when the SEP of strains of similar serotypes were analyzed or when they 
were concentrated ~  2,000-fold. 
The common occurrence of the  NSAP  in  different types of streptococci isolated 
from APSGN patients was confirmed by immunodiffusion studies. Only the SEP of 
strains obtained from patients with APSGN formed a line of identity with antiserum 
specific to the NSAP. Strains isolated from patients without APSGN or mouse passed 
strains failed to exhibit this antigen-antibody reaction. 
The  fact  that  antiserum  specific  for .the  NSAP  bound  to  the  kidney  sections 
obtained from patients with documented APSGN suggests a possible causal relation- 
ship  of this  antigen  to  the  disease  process.  The  positive  biopsies  were,  with  few 
exceptions, those that were obtained early in the course of this disease and also had 
deposits of IgG. The specificity of the immunofluorescent localization of the antiserum 
to the NSAP to the glomeruli of patients with APSGN was confirmed by absorption 
studies employing purified NSAP. These results were further strengthened by the fact 
that  the  antiserum  to the NSAP  failed to detect antigens  in  kidney biopsies  from 
patients with diseases other than APSGN. 
Although  we  still  do  not  know  whether  the  NSAP  is  to  be  found only in  the 
extracellular  products  of streptococci or  is  also  present  in  the  bacterial  cell,  it  is 
appropriate to consider its possible relationship to the pathogenesis of APSGN. The 
presence of the NSAP in the SEP of serotypes commonly associated with APSGN (1), 
coupled with its production predominantly by strains isolated from patients with this 
disease, could explain why APSGN follows infection with only a  limited number of 
streptococcal strains even within the same serotype. For example, many group A type 
12  strains  induce  pharyngitis,  but  only  those  producing  the  NSAP  would  be  of 
potential pathogenic significance in poststreptococcal glomerulonephritis. 
With  respect  to  the  discrepancies  noted  in  different  immunofluorescent studies, 
attempts  to  detect  streptococcal  antigens  in  the  kidney  biopsies  of patients  with 
APSGN  could  have  failed  for  the  following  reasons  (24,  25).  First,  the  antisera 
prepared  against  streptococcal strains  which  did  not  produce the  NSAP  (even of 
nephritogenic types) would not have contained antibodies to the NSAP and therefore 
would have failed to detect this streptococcal antigen in the kidney biopsy specimens. 
Second, because mouse passage or repeated subcultures appear to result in the loss of 
the  NSAP,  antisera  raised  against  these strains  (commonly used  in  immunization 
procedures) might not contain antibodies to the NSAP. Finally, it is conceivable that 
more than one streptococcal antigen could be involved in the pathogenesis of APSGN. H. VILLARREAL, V. A. FISCHETTI, I. VAN DE RIJN, AND J.  B. ZABRISKIE  471 
This might explain the apparently controversial results of different investigators (3, 4) 
with respect to the localization of the antigens in the streptococcal cell. 
The limited production of the NSAP  in the extracellular products of these strains, 
coupled with the technical difficulties inherent in isolating a single protein from the 
many others that form the extracellular products of streptococci, have hindered our 
efforts in characterizing the biological properties of this antigen. Specifically, it would 
be important to know whether the NSAP has a peculiar affinity for specific compo- 
nents of the glomerulus (26), whether it binds to serum proteins (27), whether it can 
activate the alternate pathway of complement (7), and finally whether immunoglob- 
ulin molecules are specifically altered by this antigen (6). These studies are currently 
underway. 
Summary 
The present report compares the extracellular proteins of streptococci by sodium 
dodecyl sulfate polyacrylamide electrophoresis. A marked variation in the streptococ- 
cal extracellular proteins  (SEP)  of different strains was  detected, even in strains of 
similar serotypes.  It  was  possible,  however,  to  identify a  single  protein  band  that 
occurred predominantly  in  the  SEP  of strains  isolated  from  patients  with  acute 
poststreptococcal glomerulonephritis (APSGN). This protein was generally not pro- 
duced by streptococci obtained from patients without this disease.  It appears to be 
immunologically similar in the various serotypes of streptococci isolated from patients 
with  APSGN  and  can  be demonstrated  by  immunofluorescence techniques  to  be 
present in the glomeruli of these patients. 
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